The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 152.50
Bid: 150.00
Ask: 155.00
Change: -5.00 (-3.17%)
Spread: 5.00 (3.333%)
Open: 157.50
High: 157.50
Low: 152.50
Prev. Close: 157.50
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Positive test results for encapsulation technology

9 Apr 2013 07:00

RNS Number : 8485B
Revolymer PLC
09 April 2013
 



9 April 2013

Revolymer plc

Revolymer's REVCAP technology delivers a potential market-breakthrough for domestic mass market liquid laundry detergents

 

Revolymer plc ("Revolymer") (AIM: REVO), the British polymer technology company, announces positive results from its latest in-house tests of its proprietary REVCAP encapsulation technology. These results demonstrate both the stabilisation of commercially important bleach actives in domestic mass market liquid laundry detergents, and the subsequent efficient release of such actives in the washing cycle. Accordingly this technology offers the potential for substantial improvement in the performance of domestic mass market liquid laundry products.

The domestic mass market liquid laundry detergent segment continues to grow more rapidly than the conventional powder domestic laundry detergent market. However, current liquid laundry main wash detergents do not contain bleach actives, which are an important constituent of most modern laundry powders and play a key role in cleaning clothes. This is because it has not, to date, been possible to stabilise such actives commonly found in laundry powders in a liquid formulation.

However, Revolymer's REVCAP encapsulation technology creates a water impermeable coating around particles of bleach active that enables them to remain stable within liquid laundry formulations. Once in a washing machine cycle, changes in the environment (e.g. in pH, concentration or ionic strength) trigger the release of the bleach active which can then play its part in cleaning the clothes.

The results from the latest in-house tests on a variety of commercially available domestic mass market liquid laundry detergents to which Revolymer's REVCAP encapsulation technology has been applied show both formulation stability for up to 28 days in accelerated testing, and efficient release of bleach actives in the washing cycle. Accordingly the REVCAP technology is now being progressed into the commercialisation phase, and management are actively working on exploiting the potential to license the technology to appropriate leading players in the market.

Revolymer will present recent underlying data on its REVCAP encapsulation technology at the 46th International Detergency Conference (www.idc.wfk.de) on Tuesday April 9th at 12.30pm at the Hilton Conference Centre, Dusseldorf, Germany; and at the 104th AOCS Annual Meeting & Expo on Tuesday April 30th at 2.40pm at the Palais des congres de Montreal in Montreal, Canada. No new material information will be disclosed at the conferences.

Roger Pettman, Chief Executive of Revolymer said: "Our in-house trials have indicated that Revolymer's REVCAP encapsulation technology achieves the stabilisation of bleach particles in domestic mass market liquid laundry detergents and their efficient release in the cleaning cycle, which could be described as the "holy grail" for detergent manufacturers. Our technology should enable bleach actives to be included in liquid laundry formulations for the first time, dramatically improving the cleaning power of these products in the future. This is a very exciting development for Revolymer and is a great example of how we are delivering our strategy of developing the next generation of polymer-enhanced products for the global FMCG markets."

Dr Paul Armitage, newly appointed VP of Commercial Development at Revolymer said: "We have made significant advances towards optimising our REVCAP encapsulation technology and the latest in-house trials are generating a significant level of interest. Clients are seriously engaging with the market changing potential afforded by the technology and are identifying opportunities for product differentiation with improved commercial value. It seems clear that a domestic mass market liquid laundry product containing REVCAP technology will have a clear competitive advantage over other liquid laundry products currently on the market, in terms of its cleaning power.

Ends

 

For further information please contact:

 

Revolymer plc

+44 (0) 1244 283 500

Roger Pettman

Rob Cridland

 

 

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Callum Stewart / Adam James (Corporate Finance)

Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)

 

Citigate Dewe Rogerson

+44 (0)20 7282 2945

David Dible / Ginny Pulbrook/Malcolm Robertson

 

 

 

About Revolymer

Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the fast moving consumer goods (FMCG) and other industrial markets. Revolymer aims to generate significant and growing high quality revenue streams by licensing its unique technologies to manufacturers and marketers within these markets. Potential applications for the business's technologies are in the household products, personal care and coatings & adhesives product areas (together "Consumer Specialties") and in medicated chewing gum (including nicotine gum) and confectionery chewing gum (together "Gum").

 

www.revolymer.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSSFMAFDSESL
Date   Source Headline
29th Apr 20247:00 amRNSLaunch of two plant-based performance ingredients
19th Apr 20247:00 amRNSGrants of Options & PDMR dealings
15th Apr 20247:00 amRNSPreliminary Results and Notice of AGM
8th Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSTrading Statement
27th Feb 20247:00 amRNSTrading Update
9th Feb 20247:00 amRNSAppointment of Non-Executive Director
26th Jan 20247:00 amRNSAppointment: Nominated Adviser and Sole Broker
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
30th Oct 20237:00 amRNSDirector/PDMR Shareholding
26th Oct 20235:28 pmRNSDirector/PDMR Shareholding
19th Oct 20235:08 pmRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
5th Oct 202311:01 amRNSHoldings in Company
12th Sep 20237:00 amRNSHalf year results
5th Sep 20237:00 amRNSNotice of Interim Results and Presentations
22nd Aug 20237:00 amRNSShare Consolidation & Total Voting Rights
15th Aug 20237:00 amRNSShare Consolidation
12th Jul 20237:00 amRNSTrading Update
28th Jun 202312:29 pmRNSAGM Statement
5th Jun 20237:00 amRNSFinal Results
24th May 20237:00 amRNSNotice of Final Results, Briefings, and AGM
25th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
2nd Mar 20233:25 pmRNSTR-1
1st Mar 20237:00 amRNSAward from Frost & Sullivan
28th Feb 20236:03 pmRNSTR-1
28th Feb 20235:04 pmRNSTR-1
28th Feb 20233:09 pmRNSTR-1
23rd Feb 20237:00 amRNSTR-1
22nd Feb 202312:28 pmRNSResults of Open Offer, GM and Total Voting Rights
15th Feb 20237:00 amRNSInvestor Presentation following GM on 22 Feb 2023
3rd Feb 20237:00 amRNSPlacing, Subscription and Open Offer; Notice of GM
5th Jan 20237:00 amRNSBoard Change
6th Dec 20224:40 pmRNSSecond Price Monitoring Extn
6th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Oct 20227:00 amRNSItaconix and Brenntag Promote Sustainable Cleaning
14th Sep 20227:00 amRNSHalf year results
13th Sep 202211:05 amRNSSecond Price Monitoring Extn
13th Sep 202211:00 amRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSNotice of Results
5th Sep 20227:00 amRNSItaconix and Croda Renew Supply Agreement
20th Jul 20227:00 amRNSBoard Change
13th Jul 20227:00 amRNSTrading Update
5th Jul 20227:00 amRNSDirectorate Change
1st Jul 20222:37 pmRNSResult of AGM
1st Jul 20229:00 amRNSPrice Monitoring Extension
1st Jul 20227:00 amRNSAGM Statement and Notice of Capital Markets Event
29th Jun 20227:00 amRNSNotice of Capital Markets Webinar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.